Glenmark

News across the web »
Interact & exchange stock tips & market info »
Related News »
Glenmark Pharmaceuticals is set to enter the final stage of clinical trials for its new drug, Revamilast, across several countries this year. It is meant for treatment of inflammatory disorders like asthma and rheumatoid arthritis. Glenmark may soon seek ...
May 24, 2012 at 19:39 | Source: Business Standard
Glenmark Pharma 's US generics arm has received tentative approval from US Food and Drugs Administration (FDA) for Zolmitriptan orally disintegrating tablets, its copy of AstraZeneca's ZomigZMT tablets. The drug is used to treat acute migraine ...
May 16, 2012 at 06:42 | Source: MoneyControl.com
As per ORG IMS MAT March 2012 data, Glenmark has gained two rank, from 25th to 23rd. Further, its market share has increased in dermatology from 8.3% to 8.4%, cardiology 2.4% to 2.5% and respiratory from 1.2% to 2.7%. Glenmark Pharma has ...
May 25, 2012 at 15:13 | Source: equitybulls.com
(RTTNews) - Glenmark Pharmaceuticals Ltd. said its US subsidiary Glenmark Generics Inc. has obtained tentative approval from US FDA for Zolmitriptan orally disintegrating tablets, its generic version of AstraZeneca's Zomig-ZMT tablets. The tentative ...
May 16, 2012 at 06:56 | Source: RTT News
New Delhi, May 16 (PTI) Glenmark Pharmaceuticals today said it has received tentative approval from the US health regulator for generic Zolmitriptan tablets used for treating migraines. Glenmark Generics Inc, the US arm of Glenmark Generic has received ...
May 16, 2012 at 12:32 | Source: MSN India
Sudarshan Sukhani of s2analytics.com is of the view that one can go long on Larsen and Toubro (L&T) and Glenmark while Tata Steel is a sell. Sukhani told CNBC-TV18, “ Larsen and Toubro needs to be traded on the long side. One has to buy it but ...
May 16, 2012 at 06:42 | Source: MoneyControl.com
Glenmark Generics Inc. USA the United States subsidiary of Glenmark Generic Limited, announced today that the United States Food and Drug Administration (U.S. FDA) has granted tentative approval for zolmitriptan orally disintegrating tablets ...
May 16, 2012 at 07:17 | Source: equitybulls.com
Glenmark Pharmaceuticals is set to enter the final stage of clinical trials for its new drug, Revamilast, across several countries this year. It is meant for treatment of inflammatory disorders like asthma and rheumatoid arthritis. Glenmark may soon seek ...
May 24, 2012 at 19:32 | Source: Business Standard
Among frontline companies, all acute focused companies, including Glenmark Pharmaceuticals Ltd, Pfizer Ltd and GlaxoSmithKline Pharmaceuticals Ltd, significantly outperformed the industry because of strong recovery in segments such as anti-infective ...
May 23, 2012 at 17:17 | Source: Livemint.com
The United States Food and Drug Administration (FDA) has granted tentative approval for Glenmark Generics Inc's (GGI), a US based subsidiary of Glenmark Pharmaceuticals Ltd, zolmitriptan orally disintegrating tablets, the generic version of AstraZeneca's ...
May 16, 2012 at 07:46 | Source: pharmabiz.com